SOUTH SAN FRANCISCO, Calif., July 5, 2007 (PRIME NEWSWIRE) -- Hana Biosciences (NasdaqGM:HNAB - News), a biopharmaceutical company focused on advancing cancer care, announced today that Mark Ahn, President & Chief Executive Officer, will present a company update at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference on Thursday, July 12, 2007 at 9:30 am EDT in Track One at the Mandarin Oriental Hotel in New York, NY.